Due to cancer cell surface-expressed GRP78 being the receptor target for GIRLRG, conjugation of GIRLRG to a sustained-release nanoparticle drug delivery system yielded increased paclitaxel concentration, apoptosis and growth delay in irradiated human breast MDA-MB-231 tumor xenografts [220]. The gene discussed is HSPA5; the disease is cancer.